Design Makes a Difference: A Meta-Analysis of Antidepressant Response Rates in Placebo-Controlled Versus Comparator Trials in Late-Life Depression
The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Abstract
Objective Qualitative reviews of late-life antidepressant clinical trials suggest that antidepressant response rates in comparator trials are higher than antidepressant response rates in placebo-controlled trials. No quantitative review has been conducted to test this hypothesis.Methods A meta-analysis was conducted of all published articles in peer-reviewed journals from 1985 to the present to identify randomized clinical trials contrasting antidepressant pharmacotherapy to placebo or an active comparator in late-life depressed outpatients. Sixteen studies (nine comparator trials and seven placebo-controlled trials) were identified. Antidepressant response rates in both placebo-controlled and comparator trials were extracted and submitted for analysis using multilevel meta-analysis procedures.Results The authors found significant variability in antidepressant response rates beyond chance. This variability decreased by 27% when the authors included study type in the model. As expected, antidepressant response rates in comparator trials were significantly higher (60%) than antidepressant response rates in placebo-controlled trials (46%).Conclusion Antidepressant response rates are higher in comparator trials as compared to placebo-controlled trials. These findings have important implications for combined medication and psychotherapy trials that use placebo-controlled medication conditions because the response rates from these conditions are likely to be lower than those from unblinded conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, results of another meta-analysis comparing placebo-controlled vs. comparator trials in LLD suggest that these effects may underestimate those in clinical settings, when patient expectations of improvement may be higher303.”
From Psychobiological factors of resilience and depression in late life (2019) · cites this paper as [303]
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Multilevel analysis techniques and applications
Hox, J. J., Moerbeek, M., & van de Schoot, R. (2002) · Cited by 6,728
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Gill, J. (2005) · Encyclopedia of Social Measurement · doi:10.1016/b0-12-369398-5/00166-3 · Cited by 3,114
Multilevel Analysis: Techniques and Applications
Robinson, T. J. (2003) · Journal of the American Statistical Association · doi:10.1198/jasa.2003.s281 · Cited by 1,039
Best evidence synthesis: An intelligent alternative to meta-analysis
Slavin, R. E. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00097-a · Cited by 949
Neurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
Roberts, J. K. (2007) · The Blackwell Encyclopedia of Sociology · doi:10.1002/9781405165518.wbeosh029 · Cited by 579
Overt versus covert treatment for pain, anxiety, and Parkinson's disease
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00908-1 · Cited by 552
Haddock, C. K., Rindskopf, D. M., & Shadish, W. R. (1998) · Psychological Methods · doi:10.1037//1082-989x.3.3.339 · Cited by 338
Self-citationVolkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Zhu, W., Maynard, L., Telang, F., Vaska, P., Ding, Y.-S., Wong, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-36-11461.2003 · Cited by 302
Antidepressants for depressed elderly
Mottram, P. G., Wilson, K., & Strobl, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003491.pub2 · Cited by 287
Hox, J. J., & De Leeuw, E. D. (1994) · Quality and Quantity · doi:10.1007/bf01097014 · Cited by 248
Unützer, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp073754 · Cited by 222
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F., Kremer, C., Rodrigues, H. E., & Murphy, G. M. (2002) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200209000-00007 · Cited by 215
Pinquart, M., Duberstein, P. R., & Lyness, J. M. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1493 · Cited by 204
Bondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.729 · Cited by 202
Roose, S. P., Sackeim, H. A., Krishnan, K. R. R., Pollock, B. G., Alexopoulos, G., Lavretsky, H., Katz, I. R., Hakkarainen, H., & Old-Old Depression Study Group (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2050 · Cited by 191
Self-citationFeighner, J. P., & Cohn, J. B. (1985) · PubMed · Cited by 171
Schneider, L. S., Nelson, J. C., Clary, C. M., Newhouse, P., Krishnan, K. R. R., Shiovitz, T., Weihs, K., & the Sertraline Elderly Depression Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1277 · Cited by 166
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Schatzberg, A. F., & Roose, S. P. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000194645.70869.3b · Cited by 158
Self-citationThe Efficacy of Antidepressants in the Treatment of Late-Life Depression
Roose, S. P., & Schatzberg, A. F. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000162807.84570.6b · Cited by 154
Self-citationBupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0309 · Cited by 150
Double-Blind, Randomized Comparison of Mirtazapine and Paroxetine in Elderly Depressed Patients
Schatzberg, A. F. (2002) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.10.5.541 · Cited by 146
Placebo mechanisms and reward circuitry: clues from Parkinson's disease
de la Fuente‐Fernández, R., Schulzer, M., & Stoessl, A. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.019 · Cited by 143
Tollefson, G. D., Bosomworth, J. C., Heiligenstein, J. H., Potvin, J. H., & Holman, S. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295001888 · Cited by 142
Escitalopram in the Treatment of Depressed Elderly Patients
Kasper, S. F., de Swart, H., & Andersen, H. F. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.10.884 · Cited by 140
Efficacy of Controlled-Release Paroxetine in the Treatment of Late-Life Depression
Rapaport, M. H., Schneider, L. S., Dunner, D. L., Davies, J. T., & Pitts, C. D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0912 · Cited by 109
Krell, H. V., Leuchter, A. F., Morgan, M., Cook, I. A., & Abrams, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0904 · Cited by 109
Volkow, N. D., Wang, G., Ma, Y., Fowler, J. S., Wong, C., Jayne, M. C., Telang, F., & Swanson, J. M. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.04.192 · Cited by 100
Dl, D., Jb, C., Walshe, T., Ck, C., Feighner, J. P., Rr, F., Jp, H., Jt, H., Ed, H., & Settle, E. C. (1992) · PubMed · Cited by 96
A double‐blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients
Guillibert, E., Pélicier, Y., Archambault, J. C., Chabannes, J.-P., Cierc, G., Desvilles, M., Guibert, M., Pagot, R., Poisat, J. L., & Thobie, Y. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb07192.x · Cited by 75
Fluoxetine Versus Trazodone in Depressed Geriatric Patients
Falk, W. E., Rosenbaum, J. F., Otto, M. W., Zusky, P. M., Weilburg, J. B., & Nixon, R. A. (1989) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198878900200407 · Cited by 70
HUTCHINSON, D. R., TONG, S., MOON, C. A. L., VINCE, M., & CLARKE, A. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00009 · Cited by 64
Fairweather, D. B., Kerr, J. S., Harrison, D. A., Moon, C. A., & Hindmarch, I. (1993) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.470080108 · Cited by 63
Buspirone and Imipramine for the Treatment of Major Depression in the Elderly
Schweizer, E., Rickels, K., Hassman, H., & Garcia-España, F. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0406 · Cited by 49
Forlenza, O. V., Almeida, O. P., Stoppe, A., Hirata, E. S., & Ferreira, R. C. R. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007475 · Cited by 42
Adjusting for publication bias: modelling the selection process
Preston, C., Ashby, D., & Smyth, R. (2004) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2003.00457.x · Cited by 34
Nair, N. P. V., Amin, M., Schwartz, G., Dastoor, D., Thavundayil, J. X., Mirmiran, J., MacDonald, C., & Phillips, R. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06185.x · Cited by 10
Antidepressant medication for the treatment of late-life depression
Roose, S. P., & Sackeïm, H. A. (2004) · doi:10.1093/oso/9780195152746.003.0016 · Cited by 5
Self-citation
Research works printed but not linked: 1
- Wilson, 2005, Antidepressants versus placebo for the depressed elderly [Systematic Review], Cochrane Database of Systematic Reviews, 4, 4
Cited by
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Armijo‐Olivo, S., Stiles, C. R., Hagen, N. A., Biondo, P. D., & Cummings, G. G. (2012) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2010.01516.x · Cited by 1,539
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
Wager, T. D., Atlas, L. Y., Leotti, L. A., & Rilling, J. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3420-10.2011 · Cited by 328
“, 2009), depression (Kirsch et al., 2008; Sneed et al., 2008; Rutherford et al., 2010), and Parkinson’s disease (de la FuenteFernandez et al.”
Background
Metadata
- Authors
- Sneed, J. R., Rutherford, B. R., Rindskopf, D., Lane, D. T., Sackeim, H. A., & Roose, S. P.
- Affiliations
- New York State Psychiatric Institute (US)
- The Graduate Center, CUNY (US)
- Corresponding author
- Sneed, Joel R.
- Venue
- The American Journal of Geriatric Psychiatry
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 16
- Issue
- 1
- Pages
- 65-73
- ISSN
- 1064-7481 (ISSN-L)
- OpenAlex
- W1979782653
- Cited by
- 140
- References
- 43
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 3 · 2021: 2 · 2020: 10 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 10 · 2015: 11 · 2014: 5 · 2013: 14 · 2012: 7
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- American Journal of Geriatric Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (T32MH020004, T32 MH 20004, K23 MH 70056-01A1, K23MH085236, T32MH015144)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- geriatric depression, antidepressant treatment, older adults, unblinding, trial design bias
- MeSH terms
- Age Factors, Aged, Antidepressive Agents, Depressive Disorder, Humans, Placebos, Research Design, Models, Statistical, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.